<DOC>
	<DOCNO>NCT02763072</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety clinic set two laser system improvement lentigines hand .</brief_summary>
	<brief_title>A Single-Center 2-Arm Study Lentigines Hands</brief_title>
	<detailed_description>The purpose study evaluate effectiveness safety clinic set two laser system treatment lentigo ( liver spot , age spot , dark sun spot ) hand .</detailed_description>
	<mesh_term>Lentigo</mesh_term>
	<criteria>1 . Female Male , 3090 year age ( inclusive ) . 2 . Fitzpatrick Skin Type I III . 3 . Desires noninvasive nonablative treatment lentigo hand ( ) . 4 . Have 4 lentigo hand ( ) . 5 . Subject must able read , understand sign Informed Consent Form . 6 . Must willing able adhere treatment followup schedule posttreatment care instruction . 7 . Willing limited sun exposure use approve sunscreen SPF 50 high treatment area every day duration study , include followup period . 8 . Willing digital photograph take treatment area agree use photograph presentation , educational marketing purpose . 9 . Agree undergo procedure ( ) treatment lentigo study , include limited chemical peel , laser light base device treatment , homeuse device treatment . 10 . Agree undergo injection botulinum toxin , collagen , hyaluronic acid filler dermal filler treatment area study . 1 . Participation clinical trial another device drug target area within 6 month prior enrollment study . 2 . Any type prior cosmetic treatment target area within 6 month study participation , laser lightbased procedure surgery . 3 . Systemic use retinoid , isotretinoin , within 6 month study participation . 4 . Use topical medication hand , antibiotic , benzoyl peroxide , retinoids ( isotretinoin ) , corticosteroid , hydroquinone , product contain dihydroxyacetone alphahydroxy concentration &gt; 8 % , within 1 month participation . 5 . History malignant tumor target area . 6 . Skin abnormalities target area , e.g. , cut , scrape , wound , scar , large mole . 7 . Pregnant . 8 . Having infection , dermatitis , rash treatment area . 9 . History keloid scarring , hypertrophic scar abnormal wound healing . 10 . Any use medication know increase sensitivity light accord investigator 's discretion . 11 . History radiation treatment area undergo systemic chemotherapy treatment cancer . 12 . History pigmentary disorder , particularly tendency hyper hypopigmentation . 13 . Anytime life , use gold therapy ( gold salt ) disorder rheumatologic disease lupus . 14 . Excessively tanned area treat unable/unlikely refrain tan study . 15 . In opinion investigator , physical mental condition might make unsafe subject participate study require systematic therapy could interfere research study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>